Rhodes D G, Sarmiento J G, Herbette L G
Mol Pharmacol. 1985 Jun;27(6):612-23.
Using the model of 1,4-dihydropyridine calcium channel-blocking drug binding to receptors in the cardiac sarcolemmal membrane, diffusion-limited rates of association were calculated for two distinct approaches. In the "aqueous approach," the drug reaches the receptor by diffusion through the bulk solvent, whereas in the "membrane approach," the drug partitions into the membrane bilayer and then diffuses laterally to a specific receptor site. Calculated rates for the membrane approach were approximately 3 orders of magnitude greater than those for the aqueous approach. The membrane approach diffusion-limited rate depends weakly on the sizes of the binding site, the drug molecule, and the vesicle, but depends strongly on ligand asymmetry. Although the measured binding rates for several 1,4-dihydropyridines were all slower than the calculated diffusion-limited rates for either model, other experimental data (such as very high partition coefficients and specific positions of these drugs in the membrane bilayer) suggest that the membrane approach is the most likely. These results have important implications for specifying critical characteristics of active 1,4-dihydropyridines.
利用1,4 - 二氢吡啶类钙通道阻滞剂与心肌肌膜受体结合的模型,针对两种不同方法计算了扩散限制的结合速率。在“水性方法”中,药物通过在大量溶剂中的扩散到达受体,而在“膜性方法”中,药物先分配进入膜双层,然后横向扩散至特定的受体位点。膜性方法计算出的速率比水性方法的速率大约高3个数量级。膜性方法的扩散限制速率对结合位点、药物分子和囊泡的大小依赖性较弱,但对配体不对称性依赖性很强。尽管几种1,4 - 二氢吡啶类药物的实测结合速率均慢于两种模型计算出的扩散限制速率,但其他实验数据(如极高的分配系数以及这些药物在膜双层中的特定位置)表明膜性方法是最有可能的。这些结果对于明确活性1,4 - 二氢吡啶类药物的关键特性具有重要意义。